Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: 0.00 (0.00%)
Spread: 0.50 (7.407%)
Open: 7.00
High: 7.00
Low: 7.00
Prev. Close: 7.00
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

22 Jul 2010 13:49

RNS Number : 7770P
Phytopharm PLC
22 July 2010
 

 

Annex DTR3

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

 

All relevant boxes should be completed in block capital letters.

 

1.

Name of the issuer

PHYTOPHARM PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

(III)

(iii) BOTH (i) AND (ii)

3.

Name of person discharging managerial

responsibilities/director

MR ROGER HICKLING, RESEARCH AND DEVELOPMENT DIRECTOR

 

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

AS 3 ABOVE

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

AS 3 ABOVE

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

OPTIONS OVER ORDINARY SHARES OF 1 PENCE EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

8.

State the nature of the transaction

 

 

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

13.

Price per share or value of transaction

 

 

 

14.

Date and place of transaction

 

 

 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

 

 

 

 

 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

 

17.

Date of grant

21 JULY 2010

 

18.

Period during which or date on which exercisable

THESE OPTIONS SHALL BE EXERCISEABLE FROM THE THIRD ANNIVERSARY OF GRANT FOR A PERIOD OF SEVEN YEARS

 

19.

Total amount paid (if any) for grant of the option

NIL

20.

Description of shares or debentures involved (class and number)

1,733,387 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

7.63 PENCE PER SHARE

 

22.

Total number of shares or debentures over which options held following notification

1,733,387 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES

23.

Any additional information

 

24.

Name of contact and telephone number for queries

ZOE MCGOWAN COMPANY SECRETARY 01480 437697

 

 

Name of authorised official of issuer responsible for making notification

ZOE MCGOWAN, COMPANY SECRETARY

Date of notification 22 JULY 2010

 

 

 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSRTMTTMBITBAM
Date   Source Headline
16th Jan 20127:00 amRNSResearch Update
11th Jan 20123:53 pmRNSBlocklisting Interim Cancellation
3rd Jan 201212:00 pmRNSBlocklisting Interim Review
28th Nov 201110:09 amRNSDirector/PDMR Shareholding
28th Nov 201110:08 amRNSDirector/PDMR Shareholding
24th Nov 20117:00 amRNSFinal Results
7th Nov 20118:51 amRNSBlocklisting Interim Review
4th Oct 20117:00 amRNSResearch Update
29th Sep 20117:00 amRNSResearch Update
16th Aug 20117:00 amRNSInterim Management Statement
28th Jul 20117:31 amRNSResearch Update
12th Jul 201112:04 pmRNSBlocklisting Interim Review
5th Jul 201112:04 pmRNSTotal Voting Rights
17th Jun 20113:28 pmRNSBlocklisting Interim Review
26th May 20117:00 amRNSHalf Yearly Report
17th May 20118:35 amRNSNotice of Results
5th May 20117:00 amRNSBlocklisting Interim Review
31st Mar 20119:07 amRNSResult of AGM
2nd Mar 201112:27 pmRNSHolding(s) in Company
15th Feb 20117:00 amRNSInterim Management Statement
7th Feb 201112:18 pmRNSAnnual Information Update
1st Feb 20118:54 amRNSTotal Voting Rights
1st Feb 20118:53 amRNSAnnual Financial Report & Notice of AGM
19th Jan 20112:14 pmRNSDirector/PDMR Shareholding
19th Jan 20112:14 pmRNSDirector/PDMR Shareholding
14th Jan 201110:18 amRNSHolding(s) in Company
10th Jan 201111:45 amRNSHolding(s) in Company
7th Jan 20111:50 pmRNSBlock Listing Application
7th Jan 201110:59 amRNSBlocklisting Application
4th Jan 20112:01 pmRNSTotal Voting Rights
21st Dec 201012:19 pmRNSDirector/PDMR Shareholding
21st Dec 201012:18 pmRNSDirector/PDMR Shareholding
14th Dec 20101:15 pmRNSBlock Listing Application
30th Nov 20107:00 amRNSFinal Results
17th Nov 201011:44 amRNSResearch Update
3rd Nov 20109:29 amRNSBlocklisting Interim Review
1st Nov 20104:31 pmRNSPreliminary Results - Change of Date
1st Nov 201010:41 amRNSNotice of Results
29th Sep 20102:00 pmRNSPresents Cogane data at scientific conferences
18th Aug 20107:00 amRNSInterim Management Statement
22nd Jul 20101:49 pmRNSDirector/PDMR Shareholding
22nd Jul 20101:49 pmRNSDirector/PDMR Shareholding
5th Jul 201010:59 amRNSChange of Registered Office
21st Jun 20107:00 amRNSAppointment of Chief Executive Officer
14th Jun 20107:00 amRNSRegulatory Approval to Begin Cogane PII Trial
24th May 20107:00 amRNSHalf Yearly Report
19th May 20104:25 pmRNSNotice of Results
4th May 20102:13 pmRNSBlocklisting Interim Review
1st Apr 201012:36 pmRNSDirector/PDMR Shareholding
1st Apr 201012:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.